- Home
- BEAT vs OPI Comparison
BEAT vs OPI Comparison
Compare BEAT & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- OPI
- Stock Information
- Founded
- BEAT 2015
- OPI 2009
- Country
- BEAT United States
- OPI United States
- Employees
- BEAT N/A
- OPI N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- OPI Real Estate Investment Trusts
- Sector
- BEAT Technology
- OPI Real Estate
- Exchange
- BEAT Nasdaq
- OPI Nasdaq
- Market Cap
- BEAT 37.7M
- OPI 40.8M
- IPO Year
- BEAT 2021
- OPI 2009
- Fundamental
- Price
- BEAT $1.41
- OPI $0.57
- Analyst Decision
- BEAT Buy
- OPI
- Analyst Count
- BEAT 1
- OPI 0
- Target Price
- BEAT $8.00
- OPI N/A
- AVG Volume (30 Days)
- BEAT 78.2K
- OPI 30.6M
- Earning Date
- BEAT 11-06-2025
- OPI 10-29-2025
- Dividend Yield
- BEAT N/A
- OPI 5.09%
- EPS Growth
- BEAT N/A
- OPI N/A
- EPS
- BEAT N/A
- OPI N/A
- Revenue
- BEAT N/A
- OPI $466,972,000.00
- Revenue This Year
- BEAT N/A
- OPI N/A
- Revenue Next Year
- BEAT $19.35
- OPI N/A
- P/E Ratio
- BEAT N/A
- OPI N/A
- Revenue Growth
- BEAT N/A
- OPI N/A
- 52 Week Low
- BEAT $0.91
- OPI $0.18
- 52 Week High
- BEAT $3.48
- OPI $2.44
- Technical
- Relative Strength Index (RSI)
- BEAT 59.24
- OPI 62.23
- Support Level
- BEAT $1.30
- OPI $0.22
- Resistance Level
- BEAT $1.39
- OPI $1.13
- Average True Range (ATR)
- BEAT 0.11
- OPI 0.12
- MACD
- BEAT 0.01
- OPI 0.06
- Stochastic Oscillator
- BEAT 61.05
- OPI 40.09
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.